157 related articles for article (PubMed ID: 26747849)
1. Bivalirudin Is Associated With Improved In-Hospital Outcomes Compared With Heparin in Percutaneous Vascular Interventions: Observational, Propensity-Matched Analysis From the Premier Hospital Database.
Kimmelstiel C; Pinto D; Aronow HD; Weintraub AR; Dangas G; Fan W; Prats J; Deliargyris EN; Katzen BT
Circ Cardiovasc Interv; 2016 Jan; 9(1):e002823. PubMed ID: 26747849
[TBL] [Abstract][Full Text] [Related]
2. Bivalirudin versus unfractionated heparin during peripheral vascular interventions: A Propensity-matched Study.
Ortiz D; Singh M; Jahangir A; Allaqaband S; Khitha J; Bajwa TK; Mewissen MW
Catheter Cardiovasc Interv; 2017 Feb; 89(3):408-413. PubMed ID: 27526661
[TBL] [Abstract][Full Text] [Related]
3. Utilization of anticoagulants and outcomes in STEMI patients undergoing PPCI in the US hospitals: Bivalirudin, heparin plus GPI or heparin alone?
Plent S; Mitchell M; Fan W; Werner R
Hosp Pract (1995); 2015; 43(3):164-71. PubMed ID: 26190670
[TBL] [Abstract][Full Text] [Related]
4. Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial.
Dangas GD; Lefèvre T; Kupatt C; Tchetche D; Schäfer U; Dumonteil N; Webb JG; Colombo A; Windecker S; Ten Berg JM; Hildick-Smith D; Mehran R; Boekstegers P; Linke A; Tron C; Van Belle E; Asgar AW; Fach A; Jeger R; Sardella G; Hink HU; Husser O; Grube E; Deliargyris EN; Lechthaler I; Bernstein D; Wijngaard P; Anthopoulos P; Hengstenberg C;
J Am Coll Cardiol; 2015 Dec; 66(25):2860-2868. PubMed ID: 26477635
[TBL] [Abstract][Full Text] [Related]
5. Bivalirudin therapy is associated with improved clinical and economic outcomes in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention: results from an observational database.
Pinto DS; Ogbonnaya A; Sherman SA; Tung P; Normand SL
Circ Cardiovasc Qual Outcomes; 2012 Jan; 5(1):52-61. PubMed ID: 22235065
[TBL] [Abstract][Full Text] [Related]
6. In-Hospital Outcome Comparing Bivalirudin to Heparin in Real-World Primary Percutaneous Coronary Intervention.
Hasun M; Dörler J; Edlinger M; Alber H; Von Lewinski D; Eber B; Roithinger FX; Berger R; Siostrzonek P; Grimm G; Benzer W; Wintersteller W; Huber K; Schuchlenz H; Weidinger F;
Am J Cardiol; 2017 Dec; 120(12):2135-2140. PubMed ID: 29103603
[TBL] [Abstract][Full Text] [Related]
7. Hemorrhagic and ischemic outcomes after bivalirudin versus unfractionated heparin during carotid artery stenting: a propensity score analysis from the NCDR.
Wayangankar SA; Abu-Fadel MS; Aronow HD; Kennedy KF; Gupta R; Yeh RW; Gray WA; Rosenfield K; Hennebry TA
Circ Cardiovasc Interv; 2013 Apr; 6(2):131-8. PubMed ID: 23532554
[TBL] [Abstract][Full Text] [Related]
8. Reduction in cardiac mortality with bivalirudin in patients with and without major bleeding: The HORIZONS-AMI trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction).
Stone GW; Clayton T; Deliargyris EN; Prats J; Mehran R; Pocock SJ
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):15-20. PubMed ID: 24140664
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes.
Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
Catheter Cardiovasc Interv; 2010 Oct; 76(4):513-24. PubMed ID: 20882655
[TBL] [Abstract][Full Text] [Related]
10. Comparison of bivalirudin and unfractionated heparin plus protamine in patients with coronary heart disease undergoing percutaneous coronary intervention (from the Antithrombotic Regimens aNd Outcome [ARNO] trial).
Parodi G; Migliorini A; Valenti R; Bellandi B; Signorini U; Moschi G; Buonamici P; Cerisano G; Antoniucci D
Am J Cardiol; 2010 Apr; 105(8):1053-9. PubMed ID: 20381652
[TBL] [Abstract][Full Text] [Related]
11. Bleeding risk comparing targeted low-dose heparin with bivalirudin in patients undergoing percutaneous coronary intervention: results from a propensity score-matched analysis of the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.
Bangalore S; Cohen DJ; Kleiman NS; Regev-Beinart T; Rao SV; Pencina MJ; Mauri L;
Circ Cardiovasc Interv; 2011 Oct; 4(5):463-73. PubMed ID: 21972401
[TBL] [Abstract][Full Text] [Related]
12. Bivalirudin for primary percutaneous coronary interventions: outcome assessment in the Ottawa STEMI registry.
Hibbert B; MacDougall A; Labinaz M; O'Brien ER; So DY; Dick A; Glover C; Froeschl M; Marquis JF; Wells GA; Blondeau M; Le May MR
Circ Cardiovasc Interv; 2012 Dec; 5(6):805-12. PubMed ID: 23149331
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation for critically ill cardiac surgery patients: is primary bivalirudin the next step?
Pappalardo F; Agracheva N; Covello RD; Pieri M; De Bonis M; Calabrò MG; Koster A; Zangrillo A
J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1013-17. PubMed ID: 24447496
[TBL] [Abstract][Full Text] [Related]
14. Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study.
Hamon M; Rao SV; Steg G; Valgimigli M; Verheugt F; Marso S; Gershlick A; Wang Y; Deliargyris E
EuroIntervention; 2012 Aug; 8(4):486-92. PubMed ID: 22668505
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical center.
Gurm HS; Rajagopal V; Fathi R; Vivekanathan D; Yadav JS; Bhatt DL; Ellis SG; Lincoff AM; Topol EJ
Am J Cardiol; 2005 Mar; 95(6):716-21. PubMed ID: 15757596
[TBL] [Abstract][Full Text] [Related]
16. Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
Bangalore S; Pencina MJ; Kleiman NS; Cohen DJ
Circ Cardiovasc Interv; 2014 Jun; 7(3):365-73. PubMed ID: 24736878
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study.
Cortese B; Micheli A; Picchi A; Bandinelli L; Brizi MG; Severi S; Limbruno U
Coron Artery Dis; 2009 Aug; 20(5):348-53. PubMed ID: 19543084
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice.
Kim LK; Wong SC; Minutello RM; Bergman G; Feldman DN
J Invasive Cardiol; 2010 Mar; 22(3):94-100. PubMed ID: 20197573
[TBL] [Abstract][Full Text] [Related]
19. Effect of bivalirudin on aortic valve intervention outcomes study: a two-centre registry study comparing bivalirudin and unfractionated heparin in balloon aortic valvuloplasty.
Kini A; Yu J; Cohen MG; Mehran R; Baber U; Sartori S; Vlachojannis GJ; Kovacic JC; Pyo R; O'Neill B; Singh V; Jacobs E; Poludasu S; Moreno P; Kim MC; Krishnan P; Sharma SK; Dangas GD
EuroIntervention; 2014 Jul; 10(3):312-9. PubMed ID: 24273237
[TBL] [Abstract][Full Text] [Related]
20. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW
Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
